TAK

Takeda Pharmaceutical

Halal Rating :
Uncomfortable
See Details
Last Price $13.37 Last updated:
Market Cap $41.33b
7D Change 2.57%
1 Year Change -20.21%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing
Exchange NYSE
Next Earnings Date

Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $1.11t $1.11t $21.79b $66.57b 1.96% 5.99%
Sept. 30, 2023 $1.04t $1.14t $46.64b $46.52b 4.47% 4.08%
June 30, 2023 $1.06t $949.62b $33.54b $59.58b 3.17% 6.27%

Company Impact

Help us evaluate Takeda Pharmaceutical's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates